Ampio Pharmaceuticals (NYSE:AMPE) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note published on Sunday. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

AMPE stock opened at $0.00 on Friday. The stock has a market capitalization of $570.00, a P/E ratio of 0.00 and a beta of 3.71. The business has a 50-day moving average of $0.02 and a 200-day moving average of $0.01. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $2.47.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.